
English
-
-
Dengue disease awareness
ISID39 minutes -
What is the diagnosis? - Challenging Pediatric ID Cases in Dengue Endemic Regions
WSPID59 minutes -
Latest Research on Dengue Science
Takeda -
Experience of a tertiary hospital in Singapore managing a dual outbreak of COVID and dengue
Takeda2 minutes -
Adverse Event Management after Dengue Vaccination
Takeda7 minutes -
Case report: Acute vision loss in a young returning traveler with dengue fever
Takeda2 minutes -
Covid-19 and dengue: Double punches for dengue-endemic countries in Asia
Takeda2 minutes -
First autochthonous dengue outbreak in Italy, August 2020
Takeda2 minutes -
Autochthonous dengue in two Dutch visiting Département Var, Southern France (July 2020)
Takeda2 minutes -
Similarities and differences between 'cytokine storms’ in acute dengue and COVID-19
Takeda2 minutes -
Dengue: Not Just 1 Virus, Not Just 1 Infection
Medscape15 minutes -
Surveillance and Reporting
Takeda5 minutes -
Dengue Phases & Guidelines
Takeda4 minutes -
Dengue infection cycle and clinical spectrum
Takeda2 minutes -
Case presentations in severe dengue: contemporary approaches to clinical management
Medscape45 minutes -
Dengue disease states
Takeda4 minutes -
Burden of Dengue
Takeda38 minutes -
Challenges in the management and diagnosis of Zika, Dengue and Chikungunya
Takeda42 minutes -
Immune response to dengue virus
Takeda4 minutes -
Managing the severely ill dengue patients – Adult and Paediatric Intensivists
ADVA92 minutes -
Clinical diagnosis and management of dengue
PAHO -
Dengue Clinical Case Management
CDC -
NS1 and its potential association with severe dengue
Takeda3 minutes -
Wanderlust meets dengue: what you need to consider as HCP?
Takeda10 minutes -
Dengue: diagnosis and treatment updates
ISID62 minutes -
Effects of dengue
Takeda7 minutes -
Causes of fever in returning travelers: A European multicenter prospective cohort study
Takeda2 minutes -
Dengue serotypes
Takeda4 minutes -
Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes
Takeda2 minutes -
A fatal case report of antibody-dependent enhancement of dengue virus type 1 following remote Zika virus infection
Takeda2 minutes -
Coagulation abnormalities in Dengue fever infection: A systematic review and meta-analysis
Takeda2 minutes -
Global, regional, and national dengue burden from 1990 to 2017
Takeda2 minutes -
A Cluster of Dengue Cases in Travelers: A Clinical Series from Thailand
Takeda2 minutes -
Dengue in Latam - Understand Disease Control and the Value of Vaccination
Takeda8 minutes -
Dengue in APAC - Understand Disease Control and the Value of Vaccination
Takeda13 minutes -
The COVID-19 pandemic should not jeopardize dengue control
Takeda2 minutes -
Dengue: A Burden Throughout the Life Course
Medscape28 minutes -
Zika and dengue but not chikungunya are associated with Guillain–Barré syndrome in Mexico: A case-control study
Takeda2 minutes
Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda
This website is intended for informational purposes only and is not a substitute for healthcare professional’s clinical knowledge or professional judgment.
© Copyright 2025 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2023